Monday, July 9, 2012
One of the major hurdles to hosting successful medicine take-back programs is the lack of sustainable funding. Pennsylvania recently introduced HB 2466 which seeks to address that hurdle. If the bill passes, come January 1, 2014, any pharmaceutical manufacturers that wish to sell their product in Pennsylvania must operate or participate in an approved pharmaceutical take-back program. This would include providing at least one collection site in each county and in every municipality with a population over 50,000 as well as providing mail-back envelopes at the collection sites and participating pharmacies. In addition to the collection sites, the bill would provide funding for an education and outreach program that would assist people in using the take-back programs. This is one to watch.